Intrathecal IgM-synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event

European Journal of Neurology

Volumn 14, Issue 8, 2007, Pages 907-911

  Schneider, R ^a   Euler, B ^a   Rauer, S ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cerebrospinal fluid; Clinically isolated syndrome; Immunoglobulin M; Isoelectric focusing; Multiple sclerosis; Oligoclonal bands

Indexed keywords

IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; HUMAN; ISOELECTRIC FOCUSING; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RECURRENT DISEASE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOBLOTTING; INTERVIEWS; ISOELECTRIC FOCUSING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34547136428     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01871.x     Document Type: Article

References (12)

1. Sharief MK, Thompson EJ. Immunoglobulin M in the cerebrospinal fluid: an indicator of recent immunological stimulation. Journal of Neurology Neurosurgery & Psychiatry 1989 52 : 949 953.
2. Perini P, Ranzato F, Calabrese M, Battistin L, Gallo P. Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry 2006 77 : 953 955.
3. Sharief MK, Thompson EJ. The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis. Annals of Neurology 1991 29 : 147 151.
4. Kaiser R, Czygan M, Kaufmann R, Lucking CH. Intrathecal IgG synthesis: when is determination of oligoclonal bands necessary? Nervenarzt 1995 66 : 618 623.
5. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988 38 : 1822 1825.
6. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001 50 : 121 127.
7. Rauer S, Euler B, Reindl M, Berger T. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event. Journal of Neurology Neurosurgery & Psychiatry 2006 77 : 739 742.
8. Kaiser R. Affinity immunoblotting: rapid and sensitive detection of oligoclonal IgG, IgA and IgM in unconcentrated CSF by agarose isoelectric focusing. Journal of the Neurological Sciences 1991 103 : 216 225.
9. Villar LM, Masjuan J, Gonzalez-Porque P, et al. Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS. Neurology 2002 59 : 555 559.
10. Villar LM, Gonzalez-Porque P, Masjuan J, Varez-Cermeno JC, Bootello A, Keir G. A sensitive and reproducible method for the detection of oligoclonal IgM bands. Journal of Immunological Methods 2001 258 : 151 155.
11. Berger T, Rubner P, Schautzer F, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. New England Journal of Medicine 2003 349 : 139 145.
12. Lim ET, Berger T, Reindl M, et al. Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. Multiple Sclerosis 2005 11 : 492 494.